DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Contract Pharmaceutical Manufacturing market - By dose formulation Type, Regions and Players - Market Size, Demand Forecasts, Industry Trends and Updates(2014-2020)" report to their offering.
The Global Contract Pharmaceutical manufacturing market is expected to reach $84 billion by 2020 from $58billion in 2014, at a CAGR of 6.4% for the forecasted period.
North America holds the major share in Global Contract Pharmaceutical manufacturing market. Asia-Pacific-especially India-is the fastest growing market. US, Canada, China, India, Japan and Australia are main countries operating in this industry.
Increasing consumption of medicines around the globe, aging population, increasing rate of approvals, adoption of novel manufacturing technologies, increasing demand for generic drugs, robust pipeline of drugs and increasing number of patent expires are some of the factors fueling the growth of this industry. Availability of skilled workforce and lower labour cost are some of the factors propelling the rapid growth of Asia-Pacific market. Increasing complexity of clinical trials, lack of in-house laboratory capacity are some of the challenges in this industry.
Key Topics Covered:
1. Market Size, Demand Forecasts, Industry Trends and Updates(2014-2020)
2. Market Overview
3. Market Dynamics
4. Global Contract Pharmaceutical Manufacturing market Segmentation, Forecasts and Trends - by Revenue
5. By Dose formulation type
6. By Region
7. Vendor Market Share Analysis
8. Company Profiles
9. Industry Structure
10. Industry M&As, Consolidations
11. Investment Opportunities
12. Global Pharmaceutical Contract Manufacturing market - Road Ahead
Companies Mentioned:
- AbbVie Contract Manufacturing
- Aenova
- Aurobindo Pharma
- Baxter BioPharma Solutions
- Biomeva
- Boehringer Ingelheim
- Catalent Pharma Solutions
- Daito Pharmaceutical
- Divis Laboratories
- Dr. Reddy's Laboratories
- Esteve Química
- Euticals
- Evonik Degussa
- Famar
- Fareva
- Jubilant
- Lonza
- Nipro Corporation
- Patheon
- Pfizer CentreSource
- Recipharm
- Royal DSM
- Shandong Xinhua Pharmaceutical
- Teva API
- Vetter Pharma
-
Zhejiang Hisun Pharmaceutical
For more information visit http://www.researchandmarkets.com/research/2ksl5q/global_contract
